Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $97.4200 (-1.58%) ($97.3500 - $99.9800) on Wed. Jan. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.36% (three month average) | RSI | 24 | Latest Price | $97.4200(-1.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.3% a day on average for past five trading days. | Weekly Trend | LGND declines -3.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) IWC(55%) XBI(55%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.18% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-14%) UUP(-5%) UNG(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.18% (StdDev 2.36%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
Resistance Level | $104.9 | 5 Day Moving Average | $100.73(-3.29%) | 10 Day Moving Average | $103.2(-5.6%) | 20 Day Moving Average | $104.9(-7.13%) | To recent high | -14.2% | To recent low | 0% | Market Cap | $1.566b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |